Difference between revisions of "Team:TP-CC San Diego/Results"

 
(45 intermediate revisions by 2 users not shown)
Line 15: Line 15:
 
     height: 250px;
 
     height: 250px;
 
     background-color: grey;
 
     background-color: grey;
 +
}
 +
 +
.cellcontainer
 +
{
 +
  width: 50%;
 +
  margin: 2% auto;
 +
}
 +
 +
.cellcontainer img
 +
{
 +
  width: 100%;
 
}
 
}
  
Line 21: Line 32:
 
   width: 85%;
 
   width: 85%;
 
   margin: 0% auto;
 
   margin: 0% auto;
−
  height: 500px;
 
 
}
 
}
  
−
.rowfirst .item
+
.rowfirst .item1
 
{
 
{
−
   width: 30%;
+
   width: 33%;
 
   float: left;
 
   float: left;
 
}
 
}
  
 +
.rowfirst .item2
 +
{
 +
  width: 33%;
 +
  float: left;
 +
}
 +
.rowfirst .item3
 +
{
 +
  margin-top: 1%;
 +
  width: 33%;
 +
  float: left;
 +
}
 +
.rowfirst .item1 span
 +
{
 +
    margin: 7px;
 +
    font-size: 15px;
 +
    /* Make the caption a block so it occupies its own line. */
 +
    display: block;
 +
    text-align: center;
 +
}
  
−
.imagefirst .item img
+
.rowfirst .item2 span
 +
{
 +
    margin: 7px;
 +
    font-size: 15px;
 +
    /* Make the caption a block so it occupies its own line. */
 +
    display: block;
 +
    text-align: center;
 +
}
 +
 
 +
.rowfirst .item3 span
 +
{
 +
    margin: 7px;
 +
    font-size: 15px;
 +
    /* Make the caption a block so it occupies its own line. */
 +
    display: block;
 +
    text-align: center;
 +
}
 +
 
 +
.rowfirst .item1 img
 
{
 
{
 
   width: 100%;
 
   width: 100%;
 +
}
 +
 +
.rowfirst .item2 img
 +
{
 +
  width: 100%;
 +
}
 +
 +
.rowfirst .item3 img
 +
{
 +
  width: 95%;
 
}
 
}
  
Line 103: Line 160:
 
<div class = "text-wrapper">
 
<div class = "text-wrapper">
  
−
 
+
<h3 class ="day"> Effects of ecDNA </h3>
−
 
+
<p style="padding: 2% 11%;font-size:16px;">There is a significantly depressed rate of cell growth due to the treatment. New cell growth, measured in the increased of density, was significantly retarded in the induced group. Based on the single factor analysis of variance test, our data after testing declares a p-value deemed low enough to reject the null hypothesis.</p>
 +
<div class="cellcontainer">
 +
<img src="https://static.igem.org/mediawiki/2017/b/ba/T--TP-CC_San_Diego--celldenovertime.png">
 +
<img src="https://static.igem.org/mediawiki/2017/6/6f/T--TP-CC_San_Diego--analysisofvariance.png">
 +
</div>
 
<h3 class ="day">Parts</h3>
 
<h3 class ="day">Parts</h3>
 
<div class="rowfirst">
 
<div class="rowfirst">
−
<div class="item">
+
<div class="item1">
−
         <img src="https://static.igem.org/mediawiki/2017/d/d5/T--TP-CC_San_Diego--k2369000.png" width="500">
+
         <img src="https://static.igem.org/mediawiki/2017/archive/d/d5/20171102014221%21T--TP-CC_San_Diego--k2369000.png">
 
         <span class="caption">BBa_K2369000</span>
 
         <span class="caption">BBa_K2369000</span>
 
</div>
 
</div>
−
<div class="item">
+
<div class="item2">
−
<img src="https://static.igem.org/mediawiki/2017/7/7b/T--TP-CC_San_Diego--k2369001.png" width="500">
+
<img src="https://static.igem.org/mediawiki/2017/archive/7/7b/20171102014242%21T--TP-CC_San_Diego--k2369001.png">
 
<span class="caption">BBa_K2369001</span>
 
<span class="caption">BBa_K2369001</span>
 
</div>
 
</div>
−
<div class="item">
+
<div class="item3">
−
<img src="https://static.igem.org/mediawiki/2017/f/f7/T--TP-CC_San_Diego--k2369002.png" width="500">
+
<img src="https://static.igem.org/mediawiki/2017/archive/f/f7/20171102014255%21T--TP-CC_San_Diego--k2369002.png">
 
<span class="caption">BBa_K2369002</span>
 
<span class="caption">BBa_K2369002</span>
 
</div>
 
</div>
Line 122: Line 183:
  
 
<h3 class ="day">Images</h3>
 
<h3 class ="day">Images</h3>
−
<h3 class = "text-title"> EGFR copy number </h3>
+
<h3 class = "text-title"> EGFR Testing </h3>
 
<center>
 
<center>
 
<div class="containertop2">
 
<div class="containertop2">
Line 132: Line 193:
 
         <img src="https://static.igem.org/mediawiki/2017/e/e2/T--TP-CC_San_Diego--GBM39.png" width="500">
 
         <img src="https://static.igem.org/mediawiki/2017/e/e2/T--TP-CC_San_Diego--GBM39.png" width="500">
 
         <span class="caption"> E1G4</span>
 
         <span class="caption"> E1G4</span>
−
    </div>
 
−
</div>
 
−
</center>
 
−
 
−
<h3 class = "text-title"> Gels </h3>
 
−
<center>
 
−
<div class="containertop3">
 
−
    <div class="item">
 
−
        <img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--TLCV2.png" width="400">
 
−
        <span class="caption"> Digested TLCV2 Vector </span>
 
−
    </div>
 
−
    <div class="item">
 
−
        <img src="https://static.igem.org/mediawiki/2017/8/83/T--TP-CC_San_Diego--pcr.png" width="280">
 
−
        <span class="caption"> PCR </span>
 
−
    </div>
 
−
    <div class="item">
 
−
        <img src="https://static.igem.org/mediawiki/2017/0/0f/T--TP-CC_San_Diego--Gel%281%29.jpg" width="350">
 
−
        <span class="caption"> GBM39 Genomic DNA </span>
 
 
     </div>
 
     </div>
 
</div>
 
</div>
Line 156: Line 199:
 
<h3 class = "text-title"> References </h3>
 
<h3 class = "text-title"> References </h3>
 
<center>
 
<center>
−
<div class="containertop3">
+
<div class="containertop2">
 
     <div class="item">
 
     <div class="item">
 
         <img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--finalplasmid.png" height="300">
 
         <img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--finalplasmid.png" height="300">
 
         <span class="caption"> Guide RNA plasmid design  </span>
 
         <span class="caption"> Guide RNA plasmid design  </span>
−
    </div>
 
−
    <div class="item">
 
−
        <img src="https://static.igem.org/mediawiki/2017/c/c8/T--TP-CC_San_Diego--12WellPlate.png" height="300">
 
−
        <span class="caption"> 12 Well Plate Design</span>
 
 
     </div>
 
     </div>
 
     <div class="item">
 
     <div class="item">
Line 172: Line 211:
 
</center>
 
</center>
  
−
<h3 class = "text-title"> STBL3 competent cell colonies containing guide RNAs </h3>
+
<h3 class = "text-title">guide RNAs </h3>
 
<center>
 
<center>
 
<div class="containertop">
 
<div class="containertop">
Line 190: Line 229:
 
     <img class = "pictures" src="https://static.igem.org/mediawiki/2017/9/94/T--TP-CC_San_Diego--e8g4.jpg" width="500">
 
     <img class = "pictures" src="https://static.igem.org/mediawiki/2017/9/94/T--TP-CC_San_Diego--e8g4.jpg" width="500">
 
         <span class="caption"> E8G3 </span>
 
         <span class="caption"> E8G3 </span>
 +
    </div>
 +
</div>
 +
</center>
 +
 +
<h3 class = "text-title"> Gels </h3>
 +
<center>
 +
<div class="containertop3">
 +
    <div class="item">
 +
        <img src="https://static.igem.org/mediawiki/2017/f/f5/T--TP-CC_San_Diego--TLCV2.png" width="400">
 +
        <span class="caption"> Digested TLCV2 Vector </span>
 +
    </div>
 +
    <div class="item">
 +
        <img src="https://static.igem.org/mediawiki/2017/8/83/T--TP-CC_San_Diego--pcr.png" width="280">
 +
        <span class="caption"> PCR </span>
 +
    </div>
 +
    <div class="item">
 +
        <img src="https://static.igem.org/mediawiki/2017/0/0f/T--TP-CC_San_Diego--Gel%281%29.jpg" width="350">
 +
        <span class="caption"> GBM39 Genomic DNA </span>
 
     </div>
 
     </div>
 
</div>
 
</div>
Line 197: Line 254:
 
<h3 class ="day">Summary</h3>
 
<h3 class ="day">Summary</h3>
 
<p style="padding: 0 11% 4% 11%;font-size: 16px;">
 
<p style="padding: 0 11% 4% 11%;font-size: 16px;">
−
We were able to confirm that the GBM39 cell line had a substantial copy number of the EGFR gene. From there, we designed 4 guide RNAs. Two from exon 1 and two from exon 8. We were unable to design any gRNA using exons 2-7 because in the GBM-39 cell line, that portion of the EGFR gene is mutated. Using the TLCV2 backbone, we removed the stuffer sequence and inserted the guideRNAs in its place.  We were successful with constructing 3 gRNAs but the 4th failed to clone twice. After Sequencing our plasmids, we transfected the guideRNAs into GBM39 cells. Currently, we are monitoring the growth of the cells.
+
We were able to confirm that the GBM39 cell line had a substantial copy number of the EGFR gene. From there, we designed 4 guide RNAs. Two from exon 1 and two from exon 8. We were unable to design any gRNA using exons 2-7 because in the GBM-39 cell line, that portion of the EGFR gene is mutated. Using the TLCV2 backbone, we removed the stuffer sequence and inserted the guideRNAs in its place.  We were successful with constructing 3 gRNAs but the 4th failed to clone twice. After Sequencing our plasmids, we transfected the guideRNAs into GBM39 cells. Currently, we are monitoring the growth of the cells, and confluency and growth of the cancerous cells has been, over the past 2 months, negatively affected in a statistically significant manner - with over a reduction in total confluency growth of over 50% when compared to the control, suggesting that our treatment has an inhibitory effect upon cancer cell growth.
 
</p>
 
</p>
 +
 
</div>
 
</div>
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 03:40, 2 November 2017

Results

Effects of ecDNA

There is a significantly depressed rate of cell growth due to the treatment. New cell growth, measured in the increased of density, was significantly retarded in the induced group. Based on the single factor analysis of variance test, our data after testing declares a p-value deemed low enough to reject the null hypothesis.

Parts

BBa_K2369000
BBa_K2369001
BBa_K2369002

Images

EGFR Testing

EGFR vs. Normalized Vector Expansion
E1G4

References

Guide RNA plasmid design
100 Basepair ladder

guide RNAs

E1G2
E1G4
E8G2
E8G3

Gels

Digested TLCV2 Vector
PCR
GBM39 Genomic DNA

Summary

We were able to confirm that the GBM39 cell line had a substantial copy number of the EGFR gene. From there, we designed 4 guide RNAs. Two from exon 1 and two from exon 8. We were unable to design any gRNA using exons 2-7 because in the GBM-39 cell line, that portion of the EGFR gene is mutated. Using the TLCV2 backbone, we removed the stuffer sequence and inserted the guideRNAs in its place. We were successful with constructing 3 gRNAs but the 4th failed to clone twice. After Sequencing our plasmids, we transfected the guideRNAs into GBM39 cells. Currently, we are monitoring the growth of the cells, and confluency and growth of the cancerous cells has been, over the past 2 months, negatively affected in a statistically significant manner - with over a reduction in total confluency growth of over 50% when compared to the control, suggesting that our treatment has an inhibitory effect upon cancer cell growth.